Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Seattle WA, Vancouver, Calgary, Sandy City UT,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase2, Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Seattle WA, Salt Lake City UT, Irvine CA, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT05477576

Phase3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Seattle WA, Orange CA, Phoenix AZ, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase1, Phase2, Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Seattle WA, Duarte CA, Orange CA, Irvine CA, Chicago IL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase1, Phase2, Recruiting

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

for
Leiomyosarcoma
Location: Seattle WA, Santa Monica CA, Phoenix AZ, Rochester MN,
Sponsor: Philogen S.p.A.

Sex: All

Age: 16 - 70+

Code: NCT03420014

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Seattle WA, San Francisco CA, Palo Alto CA,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Seattle WA, Portland OR, Salem OR, Los Angeles CA,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: Seattle WA, Portland OR, Gilbert AZ, Fargo ND,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

for
Gastrointestinal Stromal Neoplasms
Location: Seattle WA, San Francisco CA, Omaha NE, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07585266

Phase3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Seattle WA, Victoria, Vancouver, Springfield OR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

for
Sarcoma
Location: Seattle WA, Santa Monica CA, Pittsburgh PA,
Sponsor: CBA Research

Sex: All

Age: 18+

Code: NCT03002805

Phase1, Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Seattle WA, Denver CO, Gilbert AZ, Dallas TX, Tyler TX,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Seattle WA, Rochester MN, Rochester NY, Boston MA
Sponsor: Enterome

Sex: All

Age: 18+

Code: NCT04669171

Phase1, Phase2, Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

for
Mucositis, Nephrotoxicity, Ototoxicity
Location: Seattle WA, Merced CA, Santa Maria CA, La Jolla CA,
Sponsor: Matrix Biomed, Inc.

Sex: All

Age: 18+

Code: NCT03480971

Phase2, Recruiting
New

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

for
Locally Advanced Bladder Urothelial Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07667335

Phase1, Phase2, Recruiting
New

Uterine Lavage to Detect Ovarian Cancer Risk

for
BRCA Hereditary Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT07772869

Recruiting
New

A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

for
Acute Myeloid Leukemia
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07616921

Recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for
Ann Arbor Stage II Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06442475

Phase2, Recruiting

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

for
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: Seattle WA, Milwaukee WI
Sponsor: Pancreatic Cancer Research Team

Sex: All

Age: 18+

Code: NCT03634332

Phase2, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Seattle WA, Salt Lake City UT, Santa Monica CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase1, Recruiting